Disclosure Of Fair Value Measurement [Text Block]

Innate Pharma - Filing #2813423

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Disclosure of fair value measurement [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets	207 863 EUR	—	—	—	—	—	—	—	—	—	—	267 496 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity	54 151 EUR	58 103 EUR	819,000 EUR	379 637 EUR	272 213 EUR	4 011 EUR	219 404 EUR	— EUR	456,000 EUR	— EUR	1 054 EUR	107 440 EUR	1 054 EUR	52 809 EUR	— EUR	— EUR	— EUR	— EUR	375 220 EUR	3 978 EUR	156 476 EUR	63 984 EUR	3 950 EUR	355,000 EUR	372 131 EUR	155 976 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]